 | • レポートコード：20QY06-05458 • 出版社/出版日：QYResearch / 2020年6月1日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、136ページ • 納品方法：Eメール（受注後2~3営業日） • 産業分類：医薬品・医療 |
| Single User | ￥600,000 (USD4,000) | ▷ お問い合わせ |
| Multi User | ￥900,000 (USD6,000) | ▷ お問い合わせ |
| Enterprise License | ￥1,200,000 (USD8,000) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社の当調査資料では、好中球減少症薬のグローバル市場について種類別（カプセル、注射）、用途別（病院、クリニック）、地域別（北米、ヨーロッパ、中国、日本、東南アジア、インド）に区分して調査し、纏めました。2015年～2026年までの市場規模予測、主要プレイヤーの競争状況・市場シェア・企業情報、製造コスト分析、販売チャネル・流通業者・顧客情報、市場動向・機会・課題などのマーケットデータが記載されています。 ・好中球減少症薬市場の概要 ・世界の主要地域別好中球減少症薬市場規模2015-2026 ・主要プレイヤーの競争状況・市場シェア ・世界の好中球減少症薬市場規模2015-2026：種類別（カプセル、注射） ・世界の好中球減少症薬市場規模2015-2026：用途別（病院、クリニック） ・好中球減少症薬の北米市場規模2015-2020 ・好中球減少症薬のヨーロッパ市場規模2015-2020 ・好中球減少症薬の中国市場規模2015-2020 ・好中球減少症薬の日本市場規模2015-2020 ・好中球減少症薬の東南アジア市場規模2015-2020 ・好中球減少症薬のインド市場規模2015-2020 ・主要プレイヤーの企業情報：事業概要・売上・企業動向 （Apotex Inc.、Biogenomics Limited、Cellerant Therapeutics, Inc.、Coherus BioSciences, Inc.、Dr. Reddy’s Laboratories Limited、Ligand Pharmaceuticals, Inc.、NAL Pharmaceuticals Ltd.、Prolong Pharmaceuticals, LLC、Richter Gedeon Nyrt.、Sandoz International GmbH） ・好中球減少症薬の製造コスト分析 ・販売チャネル、流通業者、顧客 ・好中球減少症薬の市場動向・機会・課題 ・調査の結論 |
Market Analysis and Insights: Global Neutropenia Drugs Market
The global Neutropenia Drugs market was valued at US$ xx million in 2019 and will reach US$ xx million by the end of 2026, growing at a CAGR of xx% during 2020-2026.
Global Neutropenia Drugs Scope and Market Size
The global Neutropenia Drugs market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Neutropenia Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.
Segment by Type, the Neutropenia Drugs market is segmented into
Capsule
Injection
Segment by Application, the Neutropenia Drugs market is segmented into
Hospital
Clinic
The Neutropenia Drugs market is analysed and market size information is provided by regions (countries). Segment by Application, the Neutropenia Drugs market is segmented into United States, Europe, China, Japan, Southeast Asia, India and Rest of World.
The report includes region-wise market size for the period 2015-2026. It also includes market size and forecast by players, by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Neutropenia Drugs Market Share Analysis
Neutropenia Drugs market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Neutropenia Drugs business, the date to enter into the Neutropenia Drugs market, Neutropenia Drugs product introduction, recent developments, etc.
The major vendors covered:
Apotex Inc.
Biogenomics Limited
Cellerant Therapeutics, Inc.
Coherus BioSciences, Inc.
Dr. Reddy’s Laboratories Limited
Ligand Pharmaceuticals, Inc.
NAL Pharmaceuticals Ltd.
Prolong Pharmaceuticals, LLC
Richter Gedeon Nyrt.
Sandoz International GmbH
Table of Contents
1 Neutropenia Drugs Market Overview
1.1 Neutropenia Drugs Product Scope
1.2 Neutropenia Drugs Segment by Type
1.2.1 Global Neutropenia Drugs Sales by Type (2020-2026)
1.2.2 Capsule
1.2.3 Injection
1.3 Neutropenia Drugs Segment by Application
1.3.1 Global Neutropenia Drugs Sales Comparison by Application (2020-2026)
1.3.2 Hospital
1.3.3 Clinic
1.4 Neutropenia Drugs Market Estimates and Forecasts (2015-2026)
1.4.1 Global Neutropenia Drugs Sales Growth Rate (2015-2026)
1.4.2 Global Neutropenia Drugs Revenue and Growth Rate (2015-2026)
1.4.3 Global Neutropenia Drugs Price Trends (2015-2026)
2 Neutropenia Drugs Estimate and Forecast by Region
2.1 Global Neutropenia Drugs Market Size by Region: 2015 VS 2020 VS 2026
2.2 Global Neutropenia Drugs Retrospective Market Scenario by Region (2015-2020)
2.2.1 Global Neutropenia Drugs Sales Market Share by Region (2015-2020)
2.2.2 Global Neutropenia Drugs Revenue Market Share by Region (2015-2020)
2.3 Global Neutropenia Drugs Market Estimates and Forecasts by Region (2021-2026)
2.3.1 Global Neutropenia Drugs Sales Estimates and Forecasts by Region (2021-2026)
2.3.2 Global Neutropenia Drugs Revenue Forecast by Region (2021-2026)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 United States Neutropenia Drugs Estimates and Projections (2015-2026)
2.4.2 Europe Neutropenia Drugs Estimates and Projections (2015-2026)
2.4.3 China Neutropenia Drugs Estimates and Projections (2015-2026)
2.4.4 Japan Neutropenia Drugs Estimates and Projections (2015-2026)
2.4.5 Southeast Asia Neutropenia Drugs Estimates and Projections (2015-2026)
2.4.6 India Neutropenia Drugs Estimates and Projections (2015-2026)
3 Global Neutropenia Drugs Competition Landscape by Players
3.1 Global Top Neutropenia Drugs Players by Sales (2015-2020)
3.2 Global Top Neutropenia Drugs Players by Revenue (2015-2020)
3.3 Global Neutropenia Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Neutropenia Drugs as of 2019)
3.4 Global Neutropenia Drugs Average Price by Company (2015-2020)
3.5 Manufacturers Neutropenia Drugs Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3.7 Primary Interviews with Key Neutropenia Drugs Players (Opinion Leaders)
4 Global Neutropenia Drugs Market Size by Type
4.1 Global Neutropenia Drugs Historic Market Review by Type (2015-2020)
4.1.1 Global Neutropenia Drugs Sales Market Share by Type (2015-2020)
4.1.2 Global Neutropenia Drugs Revenue Market Share by Type (2015-2020)
4.1.3 Global Neutropenia Drugs Price by Type (2014-2020)
4.2 Global Neutropenia Drugs Market Estimates and Forecasts by Type (2021-2026)
4.2.1 Global Neutropenia Drugs Sales Forecast by Type (2021-2026)
4.2.2 Global Neutropenia Drugs Revenue Forecast by Type (2021-2026)
4.2.3 Global Neutropenia Drugs Price Forecast by Type (2021-2026)
5 Global Neutropenia Drugs Market Size by Application
5.1 Global Neutropenia Drugs Historic Market Review by Application (2015-2020)
5.1.1 Global Neutropenia Drugs Sales Market Share by Application (2015-2020)
5.1.2 Global Neutropenia Drugs Revenue Market Share by Application (2015-2020)
5.1.3 Global Neutropenia Drugs Price by Application (2015-2020)
5.2 Global Neutropenia Drugs Market Estimates and Forecasts by Application (2021-2026)
5.2.1 Global Neutropenia Drugs Sales Forecast by Application (2021-2026)
5.2.2 Global Neutropenia Drugs Revenue Forecast by Application (2021-2026)
5.2.3 Global Neutropenia Drugs Price Forecast by Application (2021-2026)
3 North America Neutropenia Drugs Market Facts & Figures
3.2 North America Neutropenia Drugs Sales Market Share by Company (2015-2020)
3.3 North America Neutropenia Drugs Sales Market Share by Type (2015-2020)
3.4 North America Neutropenia Drugs Sales Market Share by Application (2015-2020)
4 Europe Neutropenia Drugs Market Facts & Figures
4.2 Europe Neutropenia Drugs Sales Market Share by Company (2015-2020)
4.3 Europe Neutropenia Drugs Sales Market Share by Type (2015-2020)
4.4 Europe Neutropenia Drugs Sales Market Share by Application (2015-2020)
5 China Neutropenia Drugs Market Facts & Figures
5.2 China Neutropenia Drugs Sales Market Share by Company (2015-2020)
5.3 China Neutropenia Drugs Sales Market Share by Type (2015-2020)
5.4 China Neutropenia Drugs Sales Market Share by Application (2015-2020)
6 Japan Neutropenia Drugs Market Facts & Figures
6.2 Japan Neutropenia Drugs Sales Market Share by Company (2015-2020)
6.3 Japan Neutropenia Drugs Sales Market Share by Type (2015-2020)
6.4 Japan Neutropenia Drugs Sales Market Share by Application (2015-2020)
7 Southeast Asia Neutropenia Drugs Market Facts & Figures
7.2 Southeast Asia Neutropenia Drugs Sales Market Share by Company (2015-2020)
7.3 Southeast Asia Neutropenia Drugs Sales Market Share by Type (2015-2020)
7.4 Southeast Asia Neutropenia Drugs Sales Market Share by Application (2015-2020)
8 India Neutropenia Drugs Market Facts & Figures
8.2 India Neutropenia Drugs Sales Market Share by Company (2015-2020)
8.3 India Neutropenia Drugs Sales Market Share by Type (2015-2020)
8.4 India Neutropenia Drugs Sales Market Share by Application (2015-2020)
12 Company Profiles and Key Figures in Neutropenia Drugs Business
12.1 Apotex Inc.
12.1.1 Apotex Inc. Neutropenia Drugs Corporation Information
12.1.2 Apotex Inc. Neutropenia Drugs Business Overview and Total Revenue
12.1.3 Apotex Inc. Neutropenia Drugs Sales, Revenue and Gross Margin (2015-2020)
12.1.4 Apotex Inc. Neutropenia Drugs Products Offered
12.1.5 Apotex Inc. Recent Development
12.2 Biogenomics Limited
12.2.1 Biogenomics Limited Neutropenia Drugs Corporation Information
12.2.2 Biogenomics Limited Neutropenia Drugs Business Overview and Total Revenue
12.2.3 Biogenomics Limited Neutropenia Drugs Sales, Revenue and Gross Margin (2015-2020)
12.2.4 Biogenomics Limited Neutropenia Drugs Products Offered
12.2.5 Biogenomics Limited Recent Development
12.3 Cellerant Therapeutics, Inc.
12.3.1 Cellerant Therapeutics, Inc. Neutropenia Drugs Corporation Information
12.3.2 Cellerant Therapeutics, Inc. Neutropenia Drugs Business Overview and Total Revenue
12.3.3 Cellerant Therapeutics, Inc. Neutropenia Drugs Sales, Revenue and Gross Margin (2015-2020)
12.3.4 Cellerant Therapeutics, Inc. Neutropenia Drugs Products Offered
12.3.5 Cellerant Therapeutics, Inc. Recent Development
12.4 Coherus BioSciences, Inc.
12.4.1 Coherus BioSciences, Inc. Neutropenia Drugs Corporation Information
12.4.2 Coherus BioSciences, Inc. Neutropenia Drugs Business Overview and Total Revenue
12.4.3 Coherus BioSciences, Inc. Neutropenia Drugs Sales, Revenue and Gross Margin (2015-2020)
12.4.4 Coherus BioSciences, Inc. Neutropenia Drugs Products Offered
12.4.5 Coherus BioSciences, Inc. Recent Development
12.5 Dr. Reddy’s Laboratories Limited
12.5.1 Dr. Reddy’s Laboratories Limited Neutropenia Drugs Corporation Information
12.5.2 Dr. Reddy’s Laboratories Limited Neutropenia Drugs Business Overview and Total Revenue
12.5.3 Dr. Reddy’s Laboratories Limited Neutropenia Drugs Sales, Revenue and Gross Margin (2015-2020)
12.5.4 Dr. Reddy’s Laboratories Limited Neutropenia Drugs Products Offered
12.5.5 Dr. Reddy’s Laboratories Limited Recent Development
12.6 Ligand Pharmaceuticals, Inc.
12.6.1 Ligand Pharmaceuticals, Inc. Neutropenia Drugs Corporation Information
12.6.2 Ligand Pharmaceuticals, Inc. Neutropenia Drugs Business Overview and Total Revenue
12.6.3 Ligand Pharmaceuticals, Inc. Neutropenia Drugs Sales, Revenue and Gross Margin (2015-2020)
12.6.4 Ligand Pharmaceuticals, Inc. Neutropenia Drugs Products Offered
12.6.5 Ligand Pharmaceuticals, Inc. Recent Development
12.7 NAL Pharmaceuticals Ltd.
12.7.1 NAL Pharmaceuticals Ltd. Neutropenia Drugs Corporation Information
12.7.2 NAL Pharmaceuticals Ltd. Neutropenia Drugs Business Overview and Total Revenue
12.7.3 NAL Pharmaceuticals Ltd. Neutropenia Drugs Sales, Revenue and Gross Margin (2015-2020)
12.7.4 NAL Pharmaceuticals Ltd. Neutropenia Drugs Products Offered
12.7.5 NAL Pharmaceuticals Ltd. Recent Development
12.8 Prolong Pharmaceuticals, LLC
12.8.1 Prolong Pharmaceuticals, LLC Neutropenia Drugs Corporation Information
12.8.2 Prolong Pharmaceuticals, LLC Neutropenia Drugs Business Overview and Total Revenue
12.8.3 Prolong Pharmaceuticals, LLC Neutropenia Drugs Sales, Revenue and Gross Margin (2015-2020)
12.8.4 Prolong Pharmaceuticals, LLC Neutropenia Drugs Products Offered
12.8.5 Prolong Pharmaceuticals, LLC Recent Development
12.9 Richter Gedeon Nyrt.
12.9.1 Richter Gedeon Nyrt. Neutropenia Drugs Corporation Information
12.9.2 Richter Gedeon Nyrt. Neutropenia Drugs Business Overview and Total Revenue
12.9.3 Richter Gedeon Nyrt. Neutropenia Drugs Sales, Revenue and Gross Margin (2015-2020)
12.9.4 Richter Gedeon Nyrt. Neutropenia Drugs Products Offered
12.9.5 Richter Gedeon Nyrt. Recent Development
12.10 Sandoz International GmbH
12.10.1 Sandoz International GmbH Neutropenia Drugs Corporation Information
12.10.2 Sandoz International GmbH Neutropenia Drugs Business Overview and Total Revenue
12.10.3 Sandoz International GmbH Neutropenia Drugs Sales, Revenue and Gross Margin (2015-2020)
12.10.4 Sandoz International GmbH Neutropenia Drugs Products Offered
12.10.5 Sandoz International GmbH Recent Development
13 Neutropenia Drugs Manufacturing Cost Analysis
13.1 Neutropenia Drugs Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Neutropenia Drugs
13.4 Neutropenia Drugs Industrial Chain Analysis
14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Neutropenia Drugs Distributors List
14.3 Neutropenia Drugs Customers
15 Market Dynamics
15.1 Market Trends
15.2 Opportunities and Drivers
15.3 Challenges
15.4 Porter’s Five Forces Analysis
16 Research Findings and Conclusion
17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer
Table 1. Global Neutropenia Drugs Sales (K MT) Growth Rate by Type (2020-2026)
Table 2. Global Neutropenia Drugs Sales (K MT) Comparison by Application (2020-2026)
Table 3. Global Market Neutropenia Drugs Market Size (US$ Million) by Region:2015 VS 2020 &2026
Table 4. Global Neutropenia Drugs Sales (K MT) by Region (2015-2020)
Table 5. Global Neutropenia Drugs Sales Market Share by Region (2015-2020)
Table 6. Global Neutropenia Drugs Revenue (US$ Million) Market Share by Region (2015-2020))
Table 7. Global Neutropenia Drugs Revenue Share by Region (2015-2020)
Table 8. Global Neutropenia Drugs Sales (K MT) Forecast by Region (2021-2026)
Table 9. Global Neutropenia Drugs Sales Market Share Forecast by Region (2021-2026)
Table 10. Global Neutropenia Drugs Revenue (US$ Million) Forecast by Region (2021-2026)
Table 11. Global Neutropenia Drugs Revenue Share Forecast by Region (2021-2026)
Table 12. Global Neutropenia Drugs (K MT) of Key Companies (2015-2020)
Table 13. Global Neutropenia Drugs Sales Share by Company (2015-2020)
Table 14. Global Neutropenia Drugs Revenue (US$ Million) by Company (2015-2020)
Table 15. Global Neutropenia Drugs Revenue Share by Company (2015-2020)
Table 16. Global Neutropenia Drugs by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Neutropenia Drugs as of 2019)
Table 17. Global Neutropenia Drugs Average Price (USD/MT) of Key Company (2015-2020)
Table 18. Manufacturers Neutropenia Drugs Manufacturing Sites and Area Served
Table 19. Manufacturers Neutropenia Drugs Product Type
Table 20. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 21. Main Points Interviewed from Key Neutropenia Drugs Players
Table 22. Global Neutropenia Drugs Sales (K MT) by Type (2015-2020)
Table 23. Global Neutropenia Drugs Sales Share by Type (2015-2020)
Table 24. Global Neutropenia Drugs Revenue (US$ Million) Market Share by Type (2015-2020)
Table 25. Global Neutropenia Drugs Price (K MT) by Type (2015-2020)
Table 26. Global Neutropenia Drugs Sales Share by Type (2021-2026)
Table 27. Global Neutropenia Drugs Revenue (US$ Million) Market Share by Type (2021-2026)
Table 28. Global Neutropenia Drugs Revenue Share by Type (2021-2026)
Table 29. Global Neutropenia Drugs Price (K MT) by Type (2021-2026)
Table 30. Global Neutropenia Drugs Sales (K MT) by Application (2015-2020)
Table 31. Global Neutropenia Drugs Sales Share by Application (2015-2020)
Table 32. Global Neutropenia Drugs Revenue (US$ Million) Market Share by Application (2015-2020)
Table 33. Global Neutropenia Drugs Price (K MT) by Application (2015-2020)
Table 34. Global Neutropenia Drugs Sales (K MT) by Application (2021-2026)
Table 35. Global Neutropenia Drugs Sales Share by Application (2021-2026)
Table 36. Global Neutropenia Drugs Revenue (US$ Million) Market Share by Application (2021-2026)
Table 37. Global Neutropenia Drugs Revenue Share by Application (2021-2026)
Table 38. Global Neutropenia Drugs Price (K MT) by Application (2021-2026)
Table 39. United States Neutropenia Drugs Sales (K MT) by Company (2015-2020)
Table 40. United States Neutropenia Drugs Sales Market Share by Company (2015-2020)
Table 41. United States Neutropenia Drugs Sales (K MT) by Type (2015-2020)
Table 42. United States Neutropenia Drugs Sales Market Share by Type (2015-2020)
Table 43. United States Neutropenia Drugs Sales (K MT) by Application (2015-2020)
Table 44. United States Neutropenia Drugs Sales Market Share by Application (2015-2020)
Table 45. Europe Neutropenia Drugs Sales (K MT) by Company (2015-2020)
Table 46. Europe Neutropenia Drugs Sales Market Share by Company (2015-2020)
Table 47. Europe Neutropenia Drugs Sales (K MT) by Type (2015-2020)
Table 48. Europe Neutropenia Drugs Sales Market Share by Type (2015-2020)
Table 49. Europe Neutropenia Drugs Sales (K MT) by Application (2015-2020)
Table 50. Europe Neutropenia Drugs Sales Market Share by Type (2015-2020)
Table 51. China Neutropenia Drugs Sales (K MT) by Company (2015-2020)
Table 52. China Neutropenia Drugs Sales Market Share by Company (2015-2020)
Table 53. China Neutropenia Drugs Sales (K MT) by Type (2015-2020)
Table 54. China Neutropenia Drugs Sales Market Share by Type (2015-2020)
Table 55. China Neutropenia Drugs Sales (K MT) by Application (2015-2020)
Table 56. China Neutropenia Drugs Sales Market Share by Application (2015-2020)
Table 57. Japan Neutropenia Drugs Sales (K MT) by Company (2015-2020)
Table 58. Japan Neutropenia Drugs Sales Market Share by Company (2015-2020)
Table 59. Japan Neutropenia Drugs Sales (K MT) by Type (2015-2020)
Table 60. Japan Neutropenia Drugs Sales Market Share by Type (2015-2020)
Table 61. Japan Neutropenia Drugs Sales (K MT) by Application (2015-2020)
Table 62. Japan Neutropenia Drugs Sales Market Share by Application (2015-2020)
Table 63. Southeast Asia Neutropenia Drugs Sales (K MT) by Company (2015-2020)
Table 64. Southeast Asia Neutropenia Drugs Sales Market Share by Company (2015-2020)
Table 65. Southeast Asia Neutropenia Drugs Sales (K MT) by Type (2015-2020)
Table 66. Southeast Asia Neutropenia Drugs Sales Market Share by Type (2015-2020)
Table 67. Southeast Asia Neutropenia Drugs Sales (K MT) by Type (2015-2020)
Table 68. Southeast Asia Neutropenia Drugs Sales Market Share by Application (2015-2020)
Table 69. India Neutropenia Drugs Sales (K MT) by Company (2015-2020)
Table 70. India Neutropenia Drugs Sales Market Share by Company (2015-2020)
Table 71. India Neutropenia Drugs Sales (K MT) by Type (2015-2020)
Table 72. India Neutropenia Drugs Sales Market Share by Type (2015-2020)
Table 73. India Neutropenia Drugs Sales (K MT) by Application (2015-2020)
Table 74. India Neutropenia Drugs Sales Market Share by Application (2015-2020)
Table 75. Apotex Inc. Corporation Information
Table 76. Apotex Inc. Description and Business Overview
Table 77. Apotex Inc. Neutropenia Drugs Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 78. Apotex Inc. Neutropenia Drugs Product
Table 79. Apotex Inc. Recent Development
Table 80. Biogenomics Limited Corporation Information
Table 81. Biogenomics Limited Description and Business Overview
Table 82. Biogenomics Limited Neutropenia Drugs Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 83. Biogenomics Limited Neutropenia Drugs Product
Table 84. Biogenomics Limited Recent Development
Table 85. Cellerant Therapeutics, Inc. Corporation Information
Table 86. Cellerant Therapeutics, Inc. Description and Business Overview
Table 87. Cellerant Therapeutics, Inc. Neutropenia Drugs Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 88. Cellerant Therapeutics, Inc. Neutropenia Drugs Product
Table 89. Cellerant Therapeutics, Inc. Recent Development
Table 90. Coherus BioSciences, Inc. Corporation Information
Table 91. Coherus BioSciences, Inc. Description and Business Overview
Table 92. Coherus BioSciences, Inc. Neutropenia Drugs Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 93. Coherus BioSciences, Inc. Neutropenia Drugs Product
Table 94. Coherus BioSciences, Inc. Recent Development
Table 95. Dr. Reddy’s Laboratories Limited Corporation Information
Table 96. Dr. Reddy’s Laboratories Limited Description and Business Overview
Table 97. Dr. Reddy’s Laboratories Limited Neutropenia Drugs Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 98. Dr. Reddy’s Laboratories Limited Neutropenia Drugs Product
Table 99. Dr. Reddy’s Laboratories Limited Recent Development
Table 100. Ligand Pharmaceuticals, Inc. Corporation Information
Table 101. Ligand Pharmaceuticals, Inc. Description and Business Overview
Table 102. Ligand Pharmaceuticals, Inc. Neutropenia Drugs Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 103. Ligand Pharmaceuticals, Inc. Neutropenia Drugs Product
Table 104. Ligand Pharmaceuticals, Inc. Recent Development
Table 105. NAL Pharmaceuticals Ltd. Corporation Information
Table 106. NAL Pharmaceuticals Ltd. Description and Business Overview
Table 107. NAL Pharmaceuticals Ltd. Neutropenia Drugs Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 108. NAL Pharmaceuticals Ltd. Neutropenia Drugs Product
Table 109. NAL Pharmaceuticals Ltd. Recent Development
Table 110. Prolong Pharmaceuticals, LLC Corporation Information
Table 111. Prolong Pharmaceuticals, LLC Neutropenia Drugs Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 112. Prolong Pharmaceuticals, LLC Description and Business Overview
Table 113. Prolong Pharmaceuticals, LLC Neutropenia Drugs Product
Table 114. Prolong Pharmaceuticals, LLC Recent Development
Table 115. Richter Gedeon Nyrt. Corporation Information
Table 116. Richter Gedeon Nyrt. Neutropenia Drugs Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 117. Richter Gedeon Nyrt. Description and Business Overview
Table 118. Richter Gedeon Nyrt. Neutropenia Drugs Product
Table 119. Richter Gedeon Nyrt. Recent Development
Table 120. Sandoz International GmbH Corporation Information
Table 121. Sandoz International GmbH Description and Business Overview
Table 122. Sandoz International GmbH Neutropenia Drugs Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 123. Sandoz International GmbH Neutropenia Drugs Product
Table 124. Sandoz International GmbH Recent Development
Table 125. Production Base and Market Concentration Rate of Raw Material
Table 126. Key Suppliers of Raw Materials
Table 127. Neutropenia Drugs Distributors List
Table 128. Neutropenia Drugs Customers List
Table 129. Market Key Trends
Table 130. Key Opportunities and Drivers: Impact Analysis (2020-2026)
Table 131. Key Challenges
Table 132. Research Programs/Design for This Report
Table 133. Key Data Information from Secondary Sources
Table 134. Key Data Information from Primary Sources
List of Figures
Figure 1. Neutropenia Drugs Product Picture
Figure 2. Global Neutropenia Drugs Sales Market Share by Type in 2020 & 2026
Figure 3. Type I Product Picture
Figure 4. Type II Product Picture
Figure 5. Global Neutropenia Drugs Market Share by Application in 2020 & 2026
Figure 6. Hospital Examples
Figure 7. Clinic Examples
Figure 8. Global Neutropenia Drugs Sales (K MT) Growth Rate (2015-2026)
Figure 9. Global Neutropenia Drugs Revenue (US$ Million) Growth Rate (2015-2026)
Figure 10. Global Neutropenia Drugs Price Trends Growth Rate (2015-2026) (USD/MT)
Figure 11. Global Neutropenia Drugs Revenue Market Share by Region: 2015 VS 2020
Figure 12. Global Neutropenia Drugs Revenue Market Share by Region: 2021 VS 2026
Figure 13. United States Neutropenia Drugs Revenue (Million USD) Growth Rate (2015-2026)
Figure 14. United States Neutropenia Drugs Sales (K MT) Growth Rate (2015-2026)
Figure 15. Europe Neutropenia Drugs Revenue (Million USD) Growth Rate (2015-2026)
Figure 16. Europe Neutropenia Drugs Sales (Million USD) Growth Rate (2015-2026)
Figure 17. China Neutropenia Drugs Revenue (Million USD) Growth Rate (2015-2026)
Figure 18. China Neutropenia Drugs Sales (Million USD) and Growth Rate (2015-2026)
Figure 19. Japan Neutropenia Drugs Revenue (Million USD) Growth Rate (2015-2026)
Figure 20. Japan Neutropenia Drugs Sales (Million USD) Growth Rate (2015-2026)
Figure 21. Southeast Asia Neutropenia Drugs Revenue (Million USD) Growth Rate (2015-2026)
Figure 22. Southeast Asia Neutropenia Drugs Sales (Million USD) Growth Rate (2015-2026)
Figure 23. India Neutropenia Drugs Revenue (Million USD) Growth Rate (2015-2026)
Figure 24. India Neutropenia Drugs Sales (Million USD) Growth Rate (2015-2026)
Figure 25. Global 5 Largest Neutropenia Drugs Players Market Share by Revenue in Neutropenia Drugs 2015 & 2019
Figure 26. Neutropenia Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 27. Global Neutropenia Drugs Revenue Share by Type (2015-2020)
Figure 28. Global Neutropenia Drugs Revenue Growth Rate by Type in 2015 & 2019
Figure 29. Global Neutropenia Drugs Revenue Share by Application (2015-2020)
Figure 30. Global Neutropenia Drugs Revenue Growth Rate by Application in 2015 & 2019
Figure 31. United States Neutropenia Drugs Sales Market Share by Type in 2019
Figure 32. United States Neutropenia Drugs Sales Market Share by Type in 2019
Figure 33. Europe Neutropenia Drugs Sales Market Share by Company in 2019
Figure 34. Europe Neutropenia Drugs Sales Market Share by Type in 2019
Figure 35. Europe Neutropenia Drugs Sales Market Share by Application in 2019
Figure 36. China Neutropenia Drugs Sales Market Share by Company in 2019
Figure 37. China Neutropenia Drugs Sales Market Share by Type in 2019
Figure 38. China Neutropenia Drugs Sales Market Share by Application in 2019
Figure 39. Japan Neutropenia Drugs Sales Market Share by Company in 2019
Figure 40. Japan Neutropenia Drugs Sales Market Share by Type in 2019
Figure 41. Japan Neutropenia Drugs Sales Market Share by Application in 2019
Figure 42. Southeast Asia Neutropenia Drugs Sales Market Share by Company in 2019
Figure 43. Southeast Asia Neutropenia Drugs Sales Market Share by Type in 2019
Figure 44. Southeast Asia Neutropenia Drugs Sales Market Share by Application in 2019
Figure 45. India Neutropenia Drugs Sales Market Share by Company in 2019
Figure 46. India Neutropenia Drugs Sales Market Share by Type in 2019
Figure 47. India Neutropenia Drugs Sales Market Share by Application in 2019
Figure 48. Apotex Inc. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 49. Biogenomics Limited Total Revenue (US$ Million): 2019 Compared with 2018
Figure 50. Cellerant Therapeutics, Inc. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 51. Coherus BioSciences, Inc. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 52. Dr. Reddy’s Laboratories Limited Total Revenue (US$ Million): 2019 Compared with 2018
Figure 53. Ligand Pharmaceuticals, Inc. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 54. NAL Pharmaceuticals Ltd. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 55. Prolong Pharmaceuticals, LLC Total Revenue (US$ Million): 2019 Compared with 2018
Figure 56. Richter Gedeon Nyrt. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 57. Sandoz International GmbH Total Revenue (US$ Million): 2019 Compared with 2018
Figure 58. Key Raw Materials Price Trend
Figure 59. Manufacturing Cost Structure of Neutropenia Drugs
Figure 60. Manufacturing Process Analysis of Neutropenia Drugs
Figure 61. Neutropenia Drugs Industrial Chain Analysis
Figure 62. Channels of Distribution
Figure 63. Distributors Profiles
Figure 64. Porter's Five Forces Analysis
Figure 65. Bottom-up and Top-down Approaches for This Report
Figure 66. Data Triangulation
Figure 67. Key Executives Interviewed
好中球減少症治療薬の世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Neutropenia Drugs market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Neutropenia Drugs market re…- 化学療法誘発性好中球減少症（CIN）治療の世界市場 2020年：企業別、地域別、種類・用途別 Market Overview The global Chemotherapy-Induced Neutropenia (CIN) Treatment market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. …
- エクセナチド薬の世界市場レポート2020 A recently published report by QY Research titled Global Exenatide Drugs Sales Market Report 2020 is designed in a way that helps the readers to acquire a complete knowledge about the overall market scenario and it’s most lucrative sectors. The research report also statistically provides accurate da…
- コリン作動薬の世界市場レポート2020 Market Analysis and Insights: Global Cholinergic Drugs Market The global Cholinergic Drugs market was valued at US$ xx million in 2019 and will reach US$ xx million by the end of 2026, growing at a CAGR of xx% during 2020-2026. Global Cholinergic Drugs Scope and Market Size The global Cholinergic Dr…
- リラグルチド薬の世界市場レポート2020 A recently published report by QY Research titled Global Liraglutide Drugs Sales Market Report 2020 is designed in a way that helps the readers to acquire a complete knowledge about the overall market scenario and it’s most lucrative sectors. The research report also statistically provides accurate …